# Study for Naltrexone on the Abuse Potential of Methylphenidate

> **NCT03769064** · PHASE1 · COMPLETED · sponsor: **Avekshan LLC** · enrollment: 94 (actual)

## Conditions studied

- Naltrexone
- Methylphenidate Abuse

## Interventions

- **DRUG:** Placebo
- **DRUG:** Methylphenidate 60 mg
- **DRUG:** Treatment Phase Sequence 4213
- **DRUG:** Treatment Phase Sequence 2134
- **DRUG:** Treatment Phase Sequence 1342
- **DRUG:** Treatment Phase Sequence 3421

## Key facts

- **NCT ID:** NCT03769064
- **Lead sponsor:** Avekshan LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-27
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-20
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2018-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769064, "Study for Naltrexone on the Abuse Potential of Methylphenidate". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03769064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*